Chargement en cours...
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...
Enregistré dans:
| Publié dans: | Mult Scler J Exp Transl Clin |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209840/ https://ncbi.nlm.nih.gov/pubmed/34188949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20552173211022027 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|